Guardian Pharmacy Services (NYSE:GRDN) Issues Earnings Results

Guardian Pharmacy Services (NYSE:GRDN) issued its quarterly earnings data on Thursday. The company reported $0.33 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.02, FiscalAI reports. The firm had revenue of $371.07 million for the quarter, compared to analysts’ expectations of $365.76 million. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%.

Here are the key takeaways from Guardian Pharmacy Services’ conference call:

• Guardian raised 2026 guidance to revenue of $1.44 billion–$1.46 billion and Adjusted EBITDA of $136 million–$138 million. Third-quarter Adjusted EBITDA rose 24% year over year to $33.9 million, while net income nearly doubled to $19 million.
• Reported revenue fell 1.7% to $371 million, primarily due to IRA-related drug price reductions; management said revenue would have grown at a high-single-digit rate without that impact. Prescription volume increased 10% year over year.
• Growth efforts include new pharmacy locations and acquisitions, including Nautilus, whose residents were transitioned to Guardian pharmacies and whose deal is expected to be accretive after onboarding costs. Management said its acquisition pipeline remains active and sees room to expand through both acquisitions and greenfield openings.
• Management cited improving assisted-living occupancy, complex resident care needs, and Guardian’s estimated 14% share of its primary market as support for continued growth. It said service quality and facility wins—not occupancy alone—are central to expanding the business.
• Guardian is working with payers on reimbursement that better reflects its services and generic-drug mix, which management believes could improve the business’s long-term stability. The company ended the quarter with about $120 million in cash and no debt.

Guardian Pharmacy Services Trading Up 6.5%

Shares of Guardian Pharmacy Services stock traded up $2.58 during trading on Friday, reaching $42.45. The stock had a trading volume of 1,085,464 shares, compared to its average volume of 383,960. The company has a market capitalization of $2.11 billion, a price-to-earnings ratio of 36.28, a P/E/G ratio of 2.09 and a beta of 0.06. The stock has a fifty day moving average price of $41.42 and a two-hundred day moving average price of $38.30. Guardian Pharmacy Services has a 52 week low of $26.34 and a 52 week high of $48.33.

Wall Street Analysts Forecast Growth

GRDN has been the subject of several research reports. Wall Street Zen cut shares of Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a research report on Sunday, October 25th. Oppenheimer upped their price objective on Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an “outperform” rating in a report on Friday, August 7th. Truist Financial upped their price target on Guardian Pharmacy Services from $47.00 to $51.00 and gave the company a “buy” rating in a research note on Monday, September 21st. Weiss Ratings lowered Guardian Pharmacy Services from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, October 23rd. Finally, KeyCorp started coverage on Guardian Pharmacy Services in a research note on Tuesday, September 22nd. They issued an “overweight” rating and a $52.00 target price on the stock. Nine research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $45.57.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc is a provider of pharmacy services focused primarily on residents of long-term care and other institutional healthcare settings. Through its network of pharmacies, the company supplies prescription medications and related pharmacy support to assisted living communities, skilled nursing facilities, behavioral health organizations, and other care providers.

The company’s services include medication dispensing and packaging, prescription delivery, medication management, clinical pharmacy support, and technology-enabled tools designed to help caregivers and healthcare professionals manage residents’ medication regimens.